Glenmark Pharmaceuticals announced a successful midstage clinical trial of a monoclonal antibody, GBR 830, for treatment of atopic dermatitis. The company said it would launch a Phase IIb trial early in 2018.
A study in BMJ Quality and Safety found hospitals did not always agree on the definition of a pressure sore or the progression of one. Hospitals had the highest level of agreement when patients were transferred between acute care facilities and the lowest when patients transferred from a skilled nursing facility to an acute inpatient hospital.
Ohio State University scientists are investigating a wound-healing method in which a small computer chip placed on the wound site delivers programmed DNA or RNA cells into living skin cells through an electrical field. The tissue nanotransfection technique is expected to be in human trials by next year and may have potential against peripheral vascular disease.
Scientists at Northwestern University have developed thin flexible biomaterials, combining structural proteins from animal organs with polymers, that could be used for wound healing and regenerative medicine, as well as other applications. The processed material retains its biochemical and protein architecture, which stimulates cells to grow in specific ways, researchers said.
Researchers at Drexel University are developing a noninvasive treatment for chronic wounds that uses low-frequency ultrasound applied directly to the wound. Randomized, double-blinded clinical trials will take place over the next five years to verify the efficacy of the treatment and how it works on a cellular level, the Drexel researchers write in this commentary, a response to a report criticizing the lack of academic research for chronic wounds.
Although Congressional Republicans have said they want to take steps to stabilize the individual insurance market, concrete action could come too late. Insurers have spent months stressing the need for clarity on cost-sharing reduction payments and calling for other measures, but now Congress is out of town for a month, and in most states, health plans need to finalize rates in the next two weeks and finalize contracts for 2018 by the end of September.
Inspiration is never genuine if it is known as inspiration at the time. True inspiration always steals on a person.
Samuel Butler, writer
About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes.